Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

01-03-2019 | Original Paper

Decisional Capacity for Informed Consent in Males and Females with Fragile X Syndrome

Auteurs: Anne C. Wheeler, Amanda Wylie, Melissa Raspa, Adrienne Villagomez, Kylee Miller, Anne Edwards, Margaret DeRamus, Paul S. Appelbaum, Donald B. Bailey Jr.

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 5/2020

Abstract

Although informed consent is critical for all research, there is increased ethical responsibility as individuals with intellectual or developmental disabilities (IDD) become the focus of more clinical trials. This study examined decisional capacity for informed consent to clinical trials in individuals with fragile X syndrome (FXS). Participants were 152 adolescents and adults (80 males, 72 females) with FXS who completed a measure of decisional capacity and a comprehensive battery of neurocognitive and psychiatric measures. Females outperformed males on all aspects of decisional capacity. The ability to understand aspects of the clinical trial had the strongest association with the ability to appreciate and reason about the decision. Scaffolding improved understanding, suggesting researchers can take steps to improve decisional capacity and the informed consent process.

vorige artikel A Comparison of Video Prompting to Least-to-Most Prompting among Children with Autism and Intellectual Disability

volgende artikel Eating Problems in Men and Women with an Autism Spectrum Disorder

Appelbaum, P. S. (2007). Assessment of patients’ competence to consent to treatment. New England Journal of Medicine, 357(18), 1834–1840.PubMed

Appelbaum, P. S., & Grisso, T. (2001). The MacArthur Competence Assessment Tool for clinical research (MacCAT-CR). Sarasota, FL: Professional Resource Press.

Appelbaum, P. S., & Lidz, C. (2008). The therapeutic misconception. In E. J. Emanuel, C. Grady, R. A. Crouch, R. K. Lie, F. G. Miller & D. Wendler. (Eds.), The Oxford textbook of clinical research ethics. New York: Oxford University Press.

Bear, M. F., Huber, K. M., & Warren, S. T. (2004). The mGluR theory of fragile X mental retardation. Trends in Neurosciences, 27(7), 370–377.PubMed

Becker, H., Roberts, G., Morrison, J., & Silver, J. (2004). Recruiting people with disabilities as research participants: Challenges and strategies to address them. Mental Retardation, 42(6), 471–475.PubMed

Bruininks, R. H., Woodcock, R. W., Weatherman, R. F., & Hill, B. K. (1996). Scales of independent behavior—Revised comprehensive manual. Itasca, IL: Riverside Publishing.

Burket, J. A., Herndon, A. L., Winebarger, E. E., Jacome, L. F., & Deutsch, S. I. (2011). Complex effects of mGluR5 antagonism on sociability and stereotypic behaviors in mice: Possible implications for the pharmacotherapy of autism spectrum disorders. Brain Research Bulletin, 86(3–4), 152–158.PubMed

Cameron, L., & Murphy, J. (2007). Obtaining consent to participate in research: The issues involved in including people with a range of learning and communication disabilities. British Journal of Learning Disabilities, 35(2), 113–120.

Carey, E., & Griffiths, C. (2017). Recruitment and consent of adults with intellectual disabilities in a classic grounded theory research study: Ethical and methodological considerations. Disability & Society, 32(2), 193–212.

Cea, C. D., & Fisher, C. B. (2003). Health care decision-making by adults with mental retardation. Mental Retardation, 41, 78–87.PubMed

Cleaver, S., Ouellette-Kuntz, H., & Sakar, A. (2010). Participation in intellectual disability research: A review of 20 years of studies. Journal of Intellectual Disability Research, 54(3), 187–193.PubMed

Dalton, A. J., & McVilly, K. R. (2004). Ethics guidelines for international, multicenter research involving people with intellectual disabilities. Journal of Policy and Practice in Intellectual Disabilities, 1(2), 57–70.

de Vrij, F. M., Levenga, J., van der Linde, H. C., et al. (2008). Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice. Neurobiology Disease, 31(1), 127–132.

Delis, D. C., Kaplan, E., & Kramer, J. H. (2001). Delis–Kaplan executive function system™. San Antonio, TX: The Psychological Corporation.

Department of Health. (2014). The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research. The Journal of the American College of Dentists, 81(3), 4.

Dunn, L. B., Nowrangi, M. A., Palmer, B. W., Jeste, D. V., & Saks, E. R. (2006). Assessing decisional capacity for clinical research or treatment: A review of instruments. The American Journal of Psychiatry, 163, 1323–1334.PubMed

Dye, L., Hare, D. J., & Hendy, S. (2007). Capacity of people with intellectual disabilities to consent to take part in a research study. Journal of Applied Research in Intellectual Disabilities, 20(2), 168–174.

Dye, L., Hendy, S., Hare, D. J., & Burton, M. (2004). Capacity to consent to participate in research—A recontextualization. British Journal of Learning Disabilities, 32(3), 144–150.

Esbensen, A. J., Rojahn, J., Aman, M. G., & Ruedrich, S. (2003). Reliability and validity of an assessment instrument for anxiety, depression, and mood among individuals with mental retardation. Journal of Autism and Developmental Disorders, 33, 617–629.PubMed

Fisher, C. B. (2003). Goodness-of-fit ethic for informed consent to research involving adults with mental retardation and developmental disabilities. Developmental Disabilities Research Review, 9(1), 27–31.

Fisher, C. B., Cea, C. D., Davidson, P. W., & Fried, A. L. (2006). Capacity of persons with mental retardation to consent to participate in randomized clinical trials. American Journal of Psychiatry, 163(10), 1813–1820.PubMed

Freedman, R. I. (2001). Ethical challenges in the conduct of research involving persons with mental retardation. Mental Retardation, 39(2), 130–141.PubMed

Goldsmith, L., Skirton, H., & Webb, C. (2008). Informed consent to healthcare interventions in people with learning disabilities—An integrative review. Journal of Advanced Nursing, 64(6), 549–563.PubMed

Grisso, T., & Appelbaum, P. S. (1998). Assessing competence to consent to treatment: A guide for physicians and other health professionals. Oxford: Oxford University Press.

Grisso, T., & Appelbaum, P. S. (2006). Appreciating anorexia: Decisional capacity and the role of values. Philosophy, Psychiatry, & Psychology, 13(4), 293–297.

Iacono, T., & Murray, V. (2003). Issues of informed consent in conducting medical research involving people with intellectual disability. Journal of Applied Research in Intellectual Disabilities, 16(1), 41–51.

Jønch, A. E., & Jacquemont, S. (2017). Reflections on clinical trials in Fragile X Syndrome. In Fragile X syndrome (pp. 419–441).

Loesch, D. Z., Huggins, R. M., & Hagerman, R. J. (2004). Phenotypic variation and FMRP levels in fragile X. Mental Retardation and Developmental Disabilities Research Reviews, 10(1), 31–41.PubMed

Lord, C., Rutter, M., Dilavore, P. C., Risi, S., Gotham, K., & Bishop, S. L. (2012). Autism diagnostic observation schedule (2nd ed.). Los Angeles, CA: Western Psychological Services.

McDonald, K. E. (2012). We want respect”: Adults with intellectual and developmental disabilities address respect in research. American Journal on Intellectual and Developmental Disabilities, 117(4), 263–274.PubMed

McDonald, K. E., & Kidney, C. A. (2012). What is right? Ethics in intellectual disabilities research. Journal of Policy and Practice in Intellectual Disabilities, 9(1), 27–39.

McDonald, K. E., Kidney, C. A., & Patka, M. (2013). ‘You need to let your voice be heard’: Research participants’ views on research. Journal of Intellectual Disability Research, 57(3), 216–225.PubMed

Michalon, A., Sidorov, M., Ballard, T. M., et al. (2012). Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron, 74(1), 49–56.PubMed

Mitty, E. L. (2012). Decision-making and dementia. In Try this: Best practices in nursing care to older adults with dementia (D, 9).

Nugent, A. C., Miller, F. G., Henter, I. D., & Zarate, C. A. (2017). The ethics of clinical trials research in severe mood disorders. Bioethics, 31(6), 443–453.PubMedPubMedCentral

Palmer, B. W., Harmell, A. L., Pinto, L. L., Dunn, L. B., Kim, S. Y., Golshan, S., & Jeste, D. V. (2017). Determinants of capacity to consent to research on Alzheimer’s disease. Clinical Gerontologist, 40(1), 24–34.PubMed

Peisah, C., Sorinmade, O. A., Mitchell, L., & Hertogh, C. M. (2013). Decisional capacity: Toward an inclusionary approach. International Psychogeriatrics, 25(10), 1571–1579.PubMedPubMedCentral

Powers, L., Dinerstein, R., & Holmes, S. 2005. Self-advocacy, self-determination, social freedom, and opportunity. In National goals and research for people with intellectual and developmental disabilities (pp. 257–287).

Roid, G. H. (2003). Stanford Binet intelligence scales (SB5) (5th ed.). Itasca, IL: Riverside Publishing.

Rutter, M., Bailey, A., & Lord, C. (2003). Social communication questionnaire. Los Angeles, CA: Western Psychological Services.

Sansone, S. M., Schneider, A., Bickel, E., Berry-Kravis, E., Prescott, C., & Hessl, D. (2014). Improving IQ measurement in intellectual disabilities using true deviation from population norms. Journal of Neurodevelopmental Disorders, 16, 1–14.

Sheslow, D., & Adams, W. (2003). Wide range assessment of memory and learning (2nd ed.). Lutz, FL: Psychological Assessment Resources, Inc.

Shogren, K. A., Wehmeyer, M. L., Uyanik, H., & Heidrich, M. (2017). Development of the Supported Decision Making Inventory System. Intellectual and Developmental Disabilities, 55(6), 432–439.PubMed

Tam, N. T., Huy, N. T., Thoa, L. T. B., Long, N. P., Trang, N. T. H., Hirayama, K., & Karbwang, J. (2015). Participants’ understanding of informed consent in clinical trials over three decades: Systematic review and meta-analysis. Bulletin of the World Health Organization, 93, 186–198H.PubMedPubMedCentral

Thomas, A. M., Bui, N., Perkins, J. R., Yuva-Paylor, L. A., & Paylor, R. (2012). Group I metabotropic glutamate receptor antagonists alter select behaviors in a mouse model for fragile X syndrome. Psychopharmacology, 219(1), 47–58.PubMed

Walmsley, J. (2001). Normalisation, emancipatory research and inclusive research in learning disability. Disability & Society, 16(2), 187–205.

Wang, S. B., Wang, Y. Y., Ungvari, G. S., Ng, C. H., Wu, R. R., Wang, J. & Xiang, Y. T. (2017a). The MacArthur Competence Assessment Tools for assessing decision-making capacity in schizophrenia: A meta-analysis. Schizophrenia Research 183, 56–63.PubMed

Wang, Y. Y., Wang, S. B., Ungvari, G. S., Yu, X., Ng, C. H., & Xiang, Y. T. (2017b). The assessment of decision-making competence in patients with depression using the MacArthur competence assessment tools: A systematic review. Perspectives in Psychiatric Care. 54, 206–211PubMed

Woodcock, R. W., McGrew, K. S., & Mather, N. (2001, 2007). Woodcock Johnson III tests of achievement. Rolling Meadows, IL: Riverside Publishing.

Yan, Q. J., Rammal, M., Tranfaglia, M., & Bauchwitz, R. P. (2005). Suppression of two major Fragile X syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology, 49(7), 1053–1066.PubMed

Titel: Decisional Capacity for Informed Consent in Males and Females with Fragile X Syndrome
Auteurs: Anne C. Wheeler
Amanda Wylie
Melissa Raspa
Adrienne Villagomez
Kylee Miller
Anne Edwards
Margaret DeRamus
Paul S. Appelbaum
Donald B. Bailey Jr.
Publicatiedatum: 01-03-2019
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 5/2020
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-019-03930-4

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 5/2020

Brief Report: Implementation of a Specific Carbohydrate Diet for a Child with Autism Spectrum Disorder and Fragile X Syndrome

Environmental Factors Associated with Physical Activity and Screen Time Among Children With and Without Autism Spectrum Disorder

Exploring the Role of Empathy in Understanding the Social-Cognitive Profile for Individuals Referred for Autism Spectrum Disorders Assessment in Adulthood

Language Performance in Preschool-Aged Boys with Nonsyndromic Autism Spectrum Disorder or Fragile X Syndrome

A Randomized, Placebo-Controlled, Blinded, Crossover, Pilot Study of the Effects of Dextromethorphan/Quinidine for the Treatment of Neurobehavioral Symptoms in Adults with Autism

Sleep Disturbances Increase the Impact of Working Memory Deficits on Learning Problems in Adolescents with High-Functioning Autism Spectrum Disorder